iPSC-Macrophages
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- Not on record
- Points of contact
-
- NCTR Acquisition Liaison nctracquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring iPSC-Macrophages for in-vitro research use, with a solicitation estimated for release on May 1, 2027, and award anticipated on June 1, 2027. This is a new requirement with no set-aside designation.
The estimated award value ranges from $25,000 to $250,000. Inquiries should be directed to the FDA's Acquisition Liaison mailbox at nctracquisitions@fda.hhs.gov.
Forecast text
Purchase of iPSC-Macrophages for in-vitro research
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast